PharmaLectures.com

Courses › Pharma training by country › American companies that cracked Europe, and what they did differently

American companies that cracked Europe, and what they did differently

Your German and French launches stop stalling on files nobody told you were required.

  • 5 audio modulesthree lengths each
  • 50 min to 4 h 10 minbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • United States companieswho it is written for

Why this training matters

Your centralized approval arrives, and Germany still asks for more. The Federal Joint Committee benefit assessment wants a comparator your United States trial never used. Your representatives wait while competitors see the early prescribers.

What changes after this course

Your team spots national requirements months before submission and shapes the clinical data for each assessment body the first time. You hold a certificate for every learner and a training record for each person, ready for your compliance files.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your regulatory affairs team stops guessing which filings go to the European Medicines Agency and which need a local route. They draft dossiers that already answer what national competent authorities, such as Germany's Federal Institute for Drugs and Medical Devices, ask for next. The late request for more data stops arriving.

Market access directors drop the single pricing story told across the continent. They build evidence for the Federal Joint Committee benefit assessment in Germany, the French National Authority for Health and the National Institute for Health and Care Excellence in the United Kingdom, each judged on its own terms. A rejection becomes a question you have already answered.

Supply chain managers settle packaging before manufacturing starts, checking the unique identifier and anti-tampering device that the Falsified Medicines Directive and Commission Delegated Regulation 2016/161 require. Cold chain handovers follow Good Distribution Practice. Commercial leads drop patient-directed campaigns that Directive 2001/83/EC bars for prescription medicines and write plans aimed at physicians, with parallel trade priced in.

Expansion teams stop repeating the entry errors of earlier American firms. They weigh Germany as a first market, shape trial endpoints to what European regulators expect, and prepare reimbursement evidence before filing. Each step into the next country is planned in advance, not discovered in the middle of a hearing.

Who needs this training

  • Regulatory Affairs Manager

    A national body asks for local data after your centralized filing is in, and the launch date moves. With this training your team knows what each authority expects before the dossier leaves.

  • Market Access Director

    A payer rejects your price at the first meeting because the evidence was written for one country. Your team builds the value case for each assessment body, in its own terms, before the file goes in.

  • Supply Chain Manager

    A wholesaler holds a shipment because the pack lacks the required safety features. You fix the packaging and handover steps before the next batch leaves the warehouse.

  • Commercial Strategy Lead

    Your representatives cannot get meetings with an American pitch, and one slide could breach advertising rules. You rewrite their scripts around European prescribing habits and the advertising prohibitions.

Roles: Owner, CEO and board, Business development and export sales

Businesses: every kind of pharma company

Countries: United States

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Sort a planned filing into central European Medicines Agency work and national authority work before drafting starts.
  2. Check a trial design against the appropriate comparator the Federal Joint Committee is likely to require.
  3. Prepare a value summary for the French National Authority for Health and a brief for the price negotiation that follows.
  4. Rewrite a United States sales script so it stays within the advertising prohibitions of Directive 2001/83/EC.
  5. Check a pack design for the unique identifier and anti-tampering device that Commission Delegated Regulation 2016/161 requires.
  6. Spot the parallel trade risk in a pricing plan that covers several European countries.

What the company gets

  • Your launch dates stop slipping on national requests nobody planned for, because your teams know them before submission.
  • Your pricing story holds up when each national assessment body reads it on its own terms.
  • Shipments pass wholesaler and pharmacy checks because the pack carries the safety features the Falsified Medicines Directive requires.
  • Your compliance files hold a certificate for each learner and a training record for each person, ready when an auditor asks.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 5 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing50 min10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard2 h 05 min25 min a module, for regulatory, quality and business-development staff
Expanded4 h 10 min50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Owner, CEO and boardBriefing50 min
Business development and export salesBriefing50 min

Course outline: 5 modules

5 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Map which filings go to the European Medicines Agency and which stay national

    • Why a centralized European authorization still leaves launch dates in the hands of each country.
    • How to sort each filing into central or national before your team drafts a single page.
    • When to contact Germany's Federal Institute for Drugs and Medical Devices, and when to wait.
  2. 2Clear health technology assessments and secure reimbursement in each market

    • What to do when your United States trial used a comparator the Federal Joint Committee refuses to accept.
    • The benefit case that the French National Authority for Health can rate without sending you back.
    • How to prepare for price talks with the Economic Committee for Health Products in France.
  3. 3Build sales models that stay inside European advertising prohibitions

    • Why a patient-facing ad that runs freely in the United States breaks Directive 2001/83/EC.
    • How to rebuild your representatives' call plan around what European physicians actually prescribe.
    • The claim in a translated American playbook that European rules treat as unlawful promotion.
  4. 4Keep shipments moving under the Falsified Medicines Directive

    • What to change on your pack so the unique identifier and anti-tampering device pass at the wholesaler.
    • Why parallel trade pulls stock out of your low-price markets, and how to plan around it.
    • The temperature-control gaps that put a shipment out of line with Good Distribution Practice.
  5. 5Copy the market entry moves of American firms that succeeded in Europe

    • How to weigh Germany as your first launch market, with the trade-offs laid out before you commit.
    • The endpoint choices that let European regulators and assessors see the benefit you want shown.
    • What to do when French reimbursement talks stall on price, before the delay spreads to other markets.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

5 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 50 min in the briefing length and 4 h 10 min in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for United States companies. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 45 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team